EN
HI
Summary
As of 14 Sep, 2026, Novelix Pharmaceuticals stock price is ₹77.5. During the trading session, the stock has moved between an intraday low of ₹71.60 and an intraday high of ₹78.00. Over the last 52 weeks, Novelix Pharmaceuticals has traded between ₹38.00 and ₹92.00.
The stock has recorded a trading volume of 926 shares,. Its Average Traded Price (ATP) is ₹74.45, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 15 @ ₹77.50.
Novelix Pharmaceuticals has an upper circuit limit of ₹81.37 and a lower circuit limit of ₹73.63. The total value traded stands at ₹68940.70, and the delivery percentage for the day is 100%.
The stock is currently traded with a market lot size of 1. Novelix Pharmaceuticals also offers a dividend yield of 0%.
Novelix Pharmaceuticals Share Price Chart
Novelix Pharmaceuticals Share Key Metrics
Volume
926.00
Market Cap
220.64 CR
LTQ@LTP
15@77.50
ATP
74.45
Var Margin
100 %
Circuit Range
73.63-81.37
Delivery %
100 %
Value
68940.70
ASM/GSM
No
Market Lot
1
Novelix Pharmaceuticals Resistance and Support
Pivot 75.7
Resistance
First Resistance
79.8
Second Resistance
82.1
Third Resistance
86.2
Support
First Support
73.4
Second Support
69.3
Third Support
67
Novelix Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Sep 11 2026 | 78 | 77.5 | 3.32% | 78 | 71.59 |
| Thu Sep 10 2026 | 78.5 | 75.01 | -3.94% | 78.5 | 74.34 |
| Wed Sep 09 2026 | 78.09 | 78.09 | 1.68% | 80 | 78.09 |
Novelix Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-29 | Others |
| 2026-08-13 | Quarterly Results |
| 2026-06-04 | Preferential Issue of shares & Others |
| 2026-05-29 | Audited Results & Preferential issue |
| 2026-02-12 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-14 | Quarterly Results & A.G.M. |
| 2025-06-24 | Others |
| 2025-05-27 | Audited Results |
| 2025-02-12 | Quarterly Results |
| 2024-11-13 | Quarterly Results & Others |
| 2024-10-21 | To consider issue of Warrants |
| 2024-10-14 | To consider issue of Warrants |
| 2024-09-02 | Others |
| 2024-08-08 | Quarterly Results |
| 2024-03-05 | Preferential issue of shares |
Novelix Pharmaceuticals News
Novelix Pharmaceuticals Ltd - 536565 - Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On Saturday, 29Th August, 2026
Novelix Pharma has intimated a Board Meeting on August 29, 2026. The agenda includes considering and approving the Board Report for the financial year ended March 31, 2026, and the appointment of a Whole Time Director.
Aug 25 2026 18:08:15
Novelix Pharmaceuticals Ltd - 536565 - Announcement Under Regulation 30 (LODR) - Lease Deed
Novelix Pharmaceuticals has executed a 5-year land lease deed for establishing facilities for Micro Algae Cultivation and Glass Reactor Systems in Telangana. The transaction involves a promoter group member at arm's length, expanding the company's operational capabilities.
Aug 20 2026 13:21:36
Novelix Pharmaceuticals Management
| Name | Position |
|---|---|
| Venkateshwarlu Pulluru | Whole Time Director |
| Janardhan Das Kabra | Non Executive Independent Director |
Novelix Pharmaceuticals Similar Stocks
Novelix Pharmaceuticals FAQs
The Buying Price of Novelix Pharmaceuticals share is 77.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Novelix Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Novelix Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Novelix Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Novelix Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.
To assess Novelix Pharmaceuticals’s valuation compare Sector P/E, P/B which are 63.17 & 1.77 with sector averages, along with growth rates and financial metrics.
The Market Cap of Novelix Pharmaceuticals is 220.64 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Novelix Pharmaceuticals share price is 92.00 & 38.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Novelix Pharmaceuticals belongs to the Miscellaneous sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in NOVELIX
